Search Clinical Trials

Clinical Trials Search Results

The results of your search are listed below. To view the details of a trial or study, click on the see details >> link. Or start a new search.

Searched for: Breast Cancer

26 results total

Efficacy of Palonosetron in the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Following Dose Dense Adriamycin-Cyclophosphamide Chemotherapy in Early Stage Breast Cancer Patients

See details >>

Principal Investigator: Hannah Linden, MD

Study Number: 6140

Phase II Study of a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Patients with Locally Advanced or Stage IV HER2 Positive Breast Cancer

See details >>

Principal Investigator: Mary Disis, MD

Study Number: 6166

Phase I-II Study of Denileukin Diftitox (ONTAK®) in Patients with Advanced Refractory Breast Cancer

See details >>

Principal Investigator: Lupe Salazar, MD

Study Number: 6308

A Pilot Study of Vitamin D Deficiency and Myalgias, Arthralgias and/or Joint Stiffness associated with Letrozole (Femara® )

See details >>

Principal Investigator: Hannah Linden, MD

Study Number: 6346

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Maleate in Combination with Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

See details >>

Principal Investigator: Jennifer Specht, MD

Study Number: 6488

Phase II Study of Topical Imiquimod and Weekly Abraxane for the Treatment of Breast Cancer Cutaneous Metastases

See details >>

Principal Investigator: Lupe Salazar, MD

Study Number: 6578

A Phase 2 Study of [18F]fluoroestradiol (FES) as a Marker of Hormone Sensitivity of Metastatic Breast Cancer

See details >>

Principal Investigator: David Mankoff, MD, PhD

Study Number: 6590

Combined Targeted Therapies for Triple Negative Advanced Breast Cancer ? A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy with Bevacizumab and Erlotinib

See details >>

Principal Investigator: Jennifer Specht, MD

Study Number: 6628

Phase I/II Study of Adoptive T Cell Therapy Following In Vivo Priming With a HER-2/neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine in Patients With Advanced Stage HER2 Overexpressing Breast Cancer

See details >>

Principal Investigator: Mary Disis, MD

Study Number: 6658

Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (LISA)

See details >>

Principal Investigator: Julie Gralow, MD

Study Number: 6703

Displaying first 10 of 26 total results. Click to view all 26 results.

Search Options

Select a disease from the list below:

Limit results to studies enrolling:
Both Adults & Pediatrics Adults Pediatrics

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.